Epidermal growth factor receptor deficiency: Expanding the phenotype beyond infancy.
Brian R EarlMarta SzybowskaAshish MarwahaVladimir BelostotskyIrene Lara-CorralesElena PopePeter KannuPublished in: The Journal of dermatology (2020)
Transmembrane tyrosine kinase receptors represent a fundamental mechanism for transducing extracellular signals into the activation of signaling cascades responsible for intercellular communication, embryogenesis and tissue integrity. The epidermal growth factor receptor (EGFR) is a canonical member of this family, regarded for its dysregulated function in various malignancies. Here, we describe a young female born prematurely with friable and immature skin who developed chronic diarrhea, recurrent gastrointestinal and respiratory infections, as well as an ichthyotic and inflammatory papulopustular rash accompanied by alopecia. Whole-exome sequencing revealed a constitutional homozygous variant in EGFR (NM_005228.3:c1283G>A; p.[G428D]), identified as a pathogenic loss-of-function variant in three patients with EGFR deficiency. These patients succumbed to early mortality; however, the proposita's condition has stabilized, despite only supportive interventions, with dermatological improvements and reduced frequency of infections at 8 years. This report provides a clinical phenotyping of the longest surviving individual with EGFR deficiency and substantiates our understanding of the natural history of this multisystemic dermatological disorder.
Keyphrases
- epidermal growth factor receptor
- tyrosine kinase
- advanced non small cell lung cancer
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- small cell lung cancer
- cardiovascular disease
- prognostic factors
- photodynamic therapy
- risk factors
- peritoneal dialysis
- body mass index
- single cell
- transcription factor
- weight gain
- drug induced
- gestational age
- clostridium difficile
- middle aged